Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 341980, 5 pages
http://dx.doi.org/10.1155/2014/341980
Case Report

Adult Neuroblastoma Complicated by Increased Intracranial Pressure: A Case Report and Review of the Literature

1Divisions of Hematology and Oncology, Department of Medicine, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA
2Department of Pathology, Microbiology, and Immunology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University Medical Center, Nashville, TN, USA
3Division of Pediatric Hematology and Oncology, Department of Pediatrics, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Vanderbilt University Medical Center 2220 Pierce Avenue, 397 PRB, Nashville, TN 37232-6310, USA

Received 6 June 2014; Revised 30 August 2014; Accepted 3 September 2014; Published 25 September 2014

Academic Editor: Ossama W. Tawfik

Copyright © 2014 Patrick L. Stevens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. M. Brodeur, “Neuroblastoma: biological insights into a clinical enigma,” Nature Reviews Cancer, vol. 3, no. 3, pp. 203–216, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. P. Castleberry, “Neuroblastoma,” European Journal of Cancer, vol. 33, no. 9, pp. 1430–1437, 1997. View at Publisher · View at Google Scholar
  3. J. M. Maris, “Recent advances in neuroblastoma,” The New England Journal of Medicine, vol. 362, no. 23, pp. 2202–2211, 2010. View at Publisher · View at Google Scholar
  4. E. Hiyama, T. Iehara, T. Sugimoto et al., “Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study,” The Lancet, vol. 371, no. 9619, pp. 1173–1180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. B. De Bernardi, C. Pianca, P. Pistamiglio et al., “Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases,” Journal of Clinical Oncology, vol. 19, no. 1, pp. 183–190, 2001. View at Google Scholar · View at Scopus
  6. J. J. Quinn and A. J. Altman, “The multiple hematologic manifestations of neuroblastoma,” The American Journal of Pediatric Hematology/Oncology, vol. 1, no. 3, pp. 201–205, 1979. View at Publisher · View at Google Scholar · View at Scopus
  7. S. J. Kaplan, C. T. Holbrook, H. G. McDaniel, W. L. Buntain, and W. M. Crist, “Vasoactive intestinal peptide secreting tumors of childhood,” The American Journal of Diseases of Children, vol. 134, no. 1, pp. 21–24, 1980. View at Google Scholar · View at Scopus
  8. K. K. Matthay, F. Blaes, B. Hero et al., “Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004,” Cancer Letters, vol. 228, no. 1-2, pp. 275–282, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Franks, A. Bollen, R. C. Seeger, D. O. Stram, and K. K. Matthay, “Neuroblastoma in adults and adolescents: an indolent course with poor survival,” Cancer, vol. 79, pp. 2028–2035, 1997. View at Google Scholar
  10. K. Parsons, B. Bernhardt, and B. Strickland, “Targeted immunotherapy for high-risk neuroblastoma—the role of monoclonal antibodies,” Annals of Pharmacotherapy, vol. 47, no. 2, pp. 210–218, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. W. B. London, R. P. Castleberry, K. K. Matthay et al., “Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group,” Journal of Clinical Oncology, vol. 23, no. 27, pp. 6459–6465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. Kaye, M. J. Warhol, C. Kretschmar, L. Landsberg, and E. Frei III, “Neuroblastoma in adults. Three case reports and a review of the literature,” Cancer, vol. 58, no. 5, pp. 1149–1157, 1986. View at Publisher · View at Google Scholar · View at Scopus
  13. B. H. Kushner, K. Kramer, M. P. LaQuaglia, S. Modak, and N.-K. V. Cheung, “Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience,” Medical and Pediatric Oncology, vol. 41, no. 6, pp. 508–515, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Berthold, J. Boos, S. Burdach et al., “Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial,” The Lancet Oncology, vol. 6, no. 9, pp. 649–658, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. H. Kushner, K. Kramer, S. Modak, L. X. Qin, and N. K. V. Cheung, “Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma,” Cancer, vol. 116, no. 12, pp. 3054–3060, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. A. Cole and J. M. Maris, “New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome,” Clinical Cancer Research, vol. 18, no. 9, pp. 2423–2428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Yu, A. L. Gilman, M. F. Ozkaynak et al., “Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma,” The New England Journal of Medicine, vol. 363, no. 14, pp. 1324–1334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. K. K. Matthay, G. Yanik, J. Messina et al., “Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma,” Journal of Clinical Oncology, vol. 25, no. 9, pp. 1054–1060, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. K. Sahu and K. Prasad, “The opsoclonus-myoclonus syndrome,” Practical Neurology, vol. 11, no. 3, pp. 160–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Rudnick, Y. Khakoo, N. L. Antunes et al., “Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies—a report from the children's cancer group study,” Medical and Pediatric Oncology, vol. 36, no. 6, pp. 612–622, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. C. A. M. Drukker, H. A. Heij, L. C. D. Wijnaendts, J. I. M. L. Verbeke, and G. J. L. Kaspers, “Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma,” Pediatric Blood and Cancer, vol. 52, no. 3, pp. 396–398, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. de Buys Roessingh, M.-H. Loriot, C. Wiesenauer, and M. Lallier, “Lambert-Eaton myasthenic syndrome revealing an abdominal neuroblastoma,” Journal of Pediatric Surgery, vol. 44, no. 8, pp. e5–e7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Gesundheit, C. R. Smith, J. T. Gerstle, S. S. Weitzman, and H. S. L. Chan, “Ataxia and secretory diarrhea: Two unusual paraneoplastic syndromes occurring concurrently in the same patient with ganglioneuroblastoma,” Journal of Pediatric Hematology/Oncology, vol. 26, no. 9, pp. 549–552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Tatli, E. T. Saribeyoglu, N. Aydinli, M. Çalişkan, and S. Anak, “Neuroblastoma: an unusual presentation with bilateral ptosis,” Pediatric Neurology, vol. 30, no. 4, pp. 284–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Espinasse-Holder, A. S. Defachelles, J. Weill, Y. de Keyzer, E. M. de Lasalle, and B. Nelken, “Paraneoplastic cushing syndrome due to adrenal neuroblastoma,” Medical and Pediatric Oncology, vol. 34, pp. 231–233, 2000. View at Publisher · View at Google Scholar
  26. S. G. DuBois, Y. Kalika, J. N. Lukens et al., “Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival,” Journal of Pediatric Hematology/Oncology, vol. 21, no. 3, pp. 181–189, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Balaji, K. Ramachandran, and P. Kusumakumari, “Neuroimaging patterns of central nervous system metastases in neuroblastoma: report of 2 recent cases and literature review,” Journal of Child Neurology, vol. 24, no. 10, pp. 1290–1293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. M. J. Kennedy, P. Eustace, D. S. O'Briain, and P. A. Daly, “Paraneoplastic papilloedema in neuroblastoma,” Postgraduate Medical Journal, vol. 63, no. 744, pp. 873–876, 1987. View at Publisher · View at Google Scholar · View at Scopus